510(k) Report

510(k) · Cleared

Cleared

NG Delivery Catheter

K230609510(k) TraditionalCleared Sep 13, 2023191-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Balt USA, LLC · QJP Catheter, Percutaneous, Neurovasculature

Cleared on Sep 13, 2023 as substantially equivalent to K172014 (MicroVention, Inc., 2018) after a 191-day review. Its family tree reaches back 6 generations to 1996. 1 later device descends from it.

Decided
Sep 13, 2023
Review
191 days
Class
Class II
Product code
QJP
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K960806 (1996). 8 ancestors in all, the oldest K925813 (1994). 1 later device descends from it, 1 citing it directly.

  1. Root · 6 generations backK960806 Turbo TrackerTarget Therapeutics · 1996
  2. 5 generations backK994155 Excelsior 1018 MicrocatheterBoston Scientific, Target · 2000
  3. 4 generations backK013789 Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189Boston Scientific, Target · 2001 · Recalled
  4. 3 generations backK083343 Headway 17 MicrocatheterMicroVention, Inc. · 2008
  5. 2 generations backK093160 Headway 21 Microcatheter, Model: MC212150SMicroVention, Inc. · 2009
  6. 1 generation backK172014 Wedge MicrocatheterMicroVention, Inc. · 2018
  7. This deviceK230609 NG Delivery CatheterBalt USA, LLC · 2023
  8. Descendant · cites it directly · 0 of its ownK252569 Carrier XL Delivery CatheterBalt USA, LLC · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K252569Carrier XL Delivery CatheterBalt USA, LLC · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K960806Turbo TrackerTarget Therapeutics1996—
−5K994155Excelsior 1018 MicrocatheterBoston Scientific, Target2000—
−4K013789Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189Boston Scientific, Target20012
−3K083343Headway 17 MicrocatheterMicroVention, Inc.2008—
−2K093160Headway 21 Microcatheter, Model: MC212150SMicroVention, Inc.2009—
−1K172014Wedge MicrocatheterMicroVention, Inc.2018—
0 (this device)K230609NG Delivery CatheterBalt USA, LLC2023—
+1K252569Carrier XL Delivery CatheterBalt USA, LLC2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
201710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K230609, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJP device

  1. #1 K212838 Benchmark Intracranial Access Systemscore 16.9 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K172014Wedge Microcatheter
Summary page 4
…Regulation Number: 21 CFR 870.1250 Device Classification: Class II Predicate Device: Wedge Microcatheter 510(k) #: K172014 Reference Device: AXS Offset Delivery Assist Catheter 510(k) #: K163259 Device Descripti…
MicroVention, Inc.2018—
†K163259AXS Offset Delivery Assist CatheterStryker Neurovascular2017—

Also cleared against K172014: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252569Carrier XL Delivery CatheterBalt USA, LLC20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 4 companies; a new generation was cleared every 5.4 years on median.
  • 1 of the 8 ancestors has a recall of any class.
  • Of its descendants, K252569 (Balt USA, LLC, 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K172014.

How does its category compare?

All QJP devices

QJP Catheter, Percutaneous, Neurovasculature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QJP

22so far in 2026, the most since 2007

2020: 92021: 122022: 142023: 142024: 182025: 142026 (partial year): 22
2007high 22 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJP

116in 2025

2020: 72 days median2021: 139 days median2022: 206 days median2023: 184 days median2024: 188 days median2025: 116 days median2026 (partial year): 141 days median
2007high 206 (2022) · low 72 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QJP

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QJP

688in 2025

2020: 162021: 292022: 302023: 752024: 1302025: 688
2007high 688 (2025) · low 0 (2007)2025

MAUDE reports naming product code QJP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
2020972016
202112139029
202214206030
202314184075
2024181881130
2025141160688
2026221410—

What is it indicated for?

The NG Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K230609: NG Delivery Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230609

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026